Vangelis Karalis

2.0k total citations · 1 hit paper
98 papers, 1.3k citations indexed

About

Vangelis Karalis is a scholar working on Statistics and Probability, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Vangelis Karalis has authored 98 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Statistics and Probability, 15 papers in Infectious Diseases and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Vangelis Karalis's work include Statistical Methods in Clinical Trials (27 papers), Computational Drug Discovery Methods (11 papers) and Analytical Chemistry and Chromatography (10 papers). Vangelis Karalis is often cited by papers focused on Statistical Methods in Clinical Trials (27 papers), Computational Drug Discovery Methods (11 papers) and Analytical Chemistry and Chromatography (10 papers). Vangelis Karalis collaborates with scholars based in Greece, United States and France. Vangelis Karalis's co-authors include Panos Macheras, Mira Symillides, Eleni Karatza, Marilena Vlachou, Vinod P. Shah, Dimitris Papadopoulos, Angeliki Siamidi, Meletios Α. Dimopoulos, Evangelos Terpos and Ioannis P. Trougakos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Biophysical Journal.

In The Last Decade

Vangelis Karalis

91 papers receiving 1.3k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Integration of Artificial Intelligence into Clinical Practice

2024 120 citations Vangelis Karalis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vangelis Karalis Greece	21	208	202	180	146	144	98	1.3k
Yuching Yang United States	18	275 1.3×	100 0.5×	232 1.3×	84 0.6×	181 1.3×	33	1.3k
Jeffry Florian United States	19	414 2.0×	105 0.5×	92 0.5×	58 0.4×	159 1.1×	65	1.9k
Hao Zhu United States	18	315 1.5×	295 1.5×	92 0.5×	42 0.3×	184 1.3×	66	1.3k
Rabindra Patnaik United States	8	397 1.9×	251 1.2×	127 0.7×	82 0.6×	309 2.1×	11	1.8k
Martin Bergstrand Sweden	17	311 1.5×	175 0.9×	315 1.8×	225 1.5×	166 1.2×	38	2.5k
Thomas Kerbusch Netherlands	22	411 2.0×	165 0.8×	164 0.9×	49 0.3×	99 0.7×	47	1.9k
Rajanikanth Madabushi United States	19	443 2.1×	277 1.4×	56 0.3×	67 0.5×	183 1.3×	58	1.8k
Jack Cook United States	24	303 1.5×	180 0.9×	112 0.6×	217 1.5×	101 0.7×	77	1.8k
Ronald H.B. Meyboom Netherlands	25	174 0.8×	122 0.6×	72 0.4×	56 0.4×	184 1.3×	46	2.2k
Sam Haidar United States	14	135 0.6×	265 1.3×	73 0.4×	148 1.0×	174 1.2×	21	972

Countries citing papers authored by Vangelis Karalis

Since Specialization

Citations

This map shows the geographic impact of Vangelis Karalis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vangelis Karalis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vangelis Karalis more than expected).

Fields of papers citing papers by Vangelis Karalis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vangelis Karalis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vangelis Karalis. The network helps show where Vangelis Karalis may publish in the future.

Co-authorship network of co-authors of Vangelis Karalis

This figure shows the co-authorship network connecting the top 25 collaborators of Vangelis Karalis. A scholar is included among the top collaborators of Vangelis Karalis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vangelis Karalis. Vangelis Karalis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karalis, Vangelis, et al.. (2025). Generative Neural Networks for Addressing the Bioequivalence of Highly Variable Drugs. Algorithms. 18(5). 266–266.

Lambrou, George Ι., Dimitrios Vlachodimitropoulos, Anna Tagka, et al.. (2024). Type I Diabetes Mellitus Suppresses Experimental Skin Carcinogenesis. Cancers. 16(8). 1507–1507. 2 indexed citations

Karalis, Vangelis, et al.. (2024). Contact allergy caused by acrylates in nail cosmetics: A pilot study from Greece. Contact Dermatitis. 90(3). 273–279. 2 indexed citations

Karalis, Vangelis. (2023). An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence. Pharmaceuticals. 16(5). 725–725. 5 indexed citations

Kikionis, Stefanos, Anna Tagka, Alexandros Stratigos, et al.. (2022). Ulvan-Based Nanofibrous Patches Enhance Wound Healing of Skin Trauma Resulting from Cryosurgical Treatment of Keloids. Marine Drugs. 20(9). 551–551. 25 indexed citations

Robinson, Philip C., Robert Terkeltaub, Michael H. Pillinger, et al.. (2021). Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease. The American Journal of Medicine. 135(1). 32–38. 68 indexed citations

Siamidi, Angeliki, et al.. (2021). 3D-Printed Oral Dosage Forms: Mechanical Properties, Computational Approaches and Applications. Pharmaceutics. 13(9). 1401–1401. 45 indexed citations

Vlachou, Marilena & Vangelis Karalis. (2021). An In Vitro–In Vivo Simulation Approach for the Prediction of Bioequivalence. Materials. 14(3). 555–555. 15 indexed citations

Kikionis, Stefanos, Anna Tagka, Panagiotis Papagiannis, et al.. (2021). Management of Acute Radiodermatitis in Non-Melanoma Skin Cancer Patients Using Electrospun Nanofibrous Patches Loaded with Pinus halepensis Bark Extract. Cancers. 13(11). 2596–2596. 17 indexed citations

10.

Karatza, Eleni & Vangelis Karalis. (2020). Delay differential equations for the description of Irbesartan pharmacokinetics: A population approach to model absorption complexities leading to dual peaks. European Journal of Pharmaceutical Sciences. 153. 105498–105498. 9 indexed citations

11.

Kikionis, Stefanos, Angeliki Siamidi, Vangelis Karalis, et al.. (2019). In Vivo Evaluation of the Anti-Inflammatory Activity of Electrospun Micro/Nanofibrous Patches Loaded with Pinus halepensis Bark Extract on Hairless Mice Skin. Materials. 12(16). 2596–2596. 15 indexed citations

12.

Karalis, Vangelis, et al.. (2018). Laparoscopic total extraperitoneal inguinal hernia repair. Medicine. 97(52). e13974–e13974. 8 indexed citations

13.

Karalis, Vangelis, et al.. (2017). Paediatric Medicines: Regulatory and Scientific Issues. Drug Research. 67(7). 377–384. 4 indexed citations

14.

Markantonis, Sophia L., et al.. (2016). Ropivacaine, Interleukin-6 and Tumor Necrosis Factor Alpha Plasma Levels during Intermittent Epidural and Continuous Wound Infusion of Ropivacaine for Analgesia after Hysterectomy or Myomectomy: An Observational Study. Pharmacology. 98(5-6). 294–298. 2 indexed citations

15.

Karalis, Vangelis. (2015). From Bioequivalence to Biosimilarity: The Rise of a Novel Regulatory Framework. Drug Research. 66(1). 1–6. 12 indexed citations

16.

Karalis, Vangelis, Panos Macheras, & Meir Bialer. (2013). Generic Products of Antiepileptic Drugs: A Perspective on Bioequivalence, Bioavailability, and Formulation Switches Using Monte Carlo Simulations. CNS Drugs. 28(1). 69–77. 19 indexed citations

17.

Symillides, Mira, Vangelis Karalis, & Panos Macheras. (2012). Exploring the Relationships Between Scaled Bioequivalence Limits and Within-Subject Variability. Journal of Pharmaceutical Sciences. 102(1). 297–301. 2 indexed citations

18.

Karalis, Vangelis, Mira Symillides, & Panos Macheras. (2011). Bioequivalence of Highly Variable Drugs: A Comparison of the Newly Proposed Regulatory Approaches by FDA and EMA. Pharmaceutical Research. 29(4). 1066–1077. 53 indexed citations

19.

Karalis, Vangelis & Panos Macheras. (2010). Examining the Role of Metabolites in Bioequivalence Assessment. Journal of Pharmacy & Pharmaceutical Sciences. 13(2). 198–198. 10 indexed citations

20.

Kosmidis, Kosmas, Vangelis Karalis, Panos Argyrakis, & Panos Macheras. (2004). Michaelis-Menten Kinetics under Spatially Constrained Conditions: Application to Mibefradil Pharmacokinetics. Biophysical Journal. 87(3). 1498–1506. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact